Sign for Notice Everyday    Sign Up| Sign In| Link|

Our Sponsors

  • ESTA - Electronic System for Travel Authorization
Receive Latest News

Feedburner
Share Us

Current Concepts and (Future Trends) for Effective Immunization

View: 20

Website https://www.compliance4all.com/control/w_product/~product_id=502228LIVE?channel=ourglocal_Dec_2018_S | Edit Freely

Category Health Personnel, Academicians, Pediatricians

Deadline: December 08, 2018 | Date: December 10, 2018

Venue/Country: Online, U.S.A

Updated: 2018-10-08 14:42:28 (GMT+9)

Call For Papers - CFP

Overview:

How to choose the vaccine for different age groups. The nasal influenza

vaccine. Quadrivalent cell culture vaccine. Non egg adapted influenza

vaccines for kids. Recent advances and future developments will be

discussed.

Areas Covered in the Session:

About the disease epidemiology

Current vaccine strains , matching and possible efficacy

How to overcome impediments to reduced efficacy to AH3N2

Vaccines produced on baculoviruses

CDC recommendations

Who Will Benefit:

Pharmacists

Doctors

Vaccinologists

Nurses

Health Personnel

Academicians

Speaker Profile:

Dr. Subodh Bhardwaj is a Medical and Scientific Affairs expert and a

Senior Scientist with three decades of experience leading research and

development of Vaccines and biopharmaceuticals in the pharmaceutical

industry.

Event Fee: One Dial-in One Attendee Price: US$150.00

Contact Detail:

Compliance4All DBA NetZealous,

Phone: +1-800-447-9407

Email: support@compliance4All.com


Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.